Kelsey S Lau-Min

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing

H. Hakonarson, J. Landgraf, M. Harr, 2022, Frontiers in Oncology.

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation

N. Reddy, S. Tuteja, U. Teitelbaum, 2022, BMC cancer.

From Race-Based to Precision Oncology: Leveraging Behavioral Economics and the Electronic Health Record to Advance Health Equity in Cancer Care.

K. Nathanson, J. Bekelman, Carmen E. Guerra, 2021, JCO precision oncology.

Impact of integrating genomic data into the electronic health record on genetics care delivery.

K. Nathanson, M. Ritchie, S. Domchek, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Adherence to and determinants of guideline‐recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice

N. Meropol, Yimei Li, R. Mamtani, 2021, Cancer.

Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative

K. Nathanson, M. Ritchie, M. Feldman, 2020, Genetics in Medicine.

Processes of code status transitions in hospitalized patients with advanced cancer

L. Traeger, J. Temel, D. Ryan, 2017, Cancer.

DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation

N. Reddy, S. Tuteja, U. Teitelbaum, 2020, Pharmacotherapy.

Outcomes Among Minority Patients With Metastatic Colorectal Cancer in a Safety-net Health Care System.

S. Hilsenbeck, A. Thrift, E. Jo, 2020, Clinical colorectal cancer.

Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian Cancer.

K. Nathanson, S. Domchek, A. McCarthy, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.